# Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

> **NCT05832593** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 52 (estimated)

## Conditions studied

- Laryngeal Squamous Cell Carcinoma

## Interventions

- **OTHER:** Immunohistochemistry

## Key facts

- **NCT ID:** NCT05832593
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-10
- **Final completion:** 2025-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05832593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05832593, "Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05832593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*